BACKGROUND: Health care for people living with HIV has improved substantially in the past two decades. Robust estimates of how these improvements have affected prognosis and life expectancy are of utmost importance to patients, clinicians, and health-care planners. We examined changes in 3 year survival and life expectancy of patients starting combination antiretroviral therapy (ART)…
The Lancet HIV Template
Write in a clean editor, then format for The Lancet HIV in one click — DocuGuru applies the official Clinical & Medical Journals template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the The Lancet HIV format
The Lancet HIV is a peer-reviewed journal published by Clinical & Medical Journals, covering HIV/AIDS Research and Interventions, HIV, Drug Use, Sexual Risk, HIV/AIDS drug development and treatment. Over its lifetime it has published 2,037 papers, which have received 57,227 citations.
| Publisher | Clinical & Medical Journals |
|---|---|
| Reference style | Numbered (Vancouver) Numbered — [1], [2] in the text 1. Smith A, Jones B, Lee C. A representative article title. The Lancet HIV. 2023;12(3):45–58.
Formats any DOI in The Lancet HIV style. No sign-up. |
| Publishes research in | HIV/AIDS Research and Interventions HIV, Drug Use, Sexual Risk HIV/AIDS drug development and treatment HIV Research and Treatment HIV-related health complications and treatments |
| ISSN | 2352-3018 |
| Citation impact (2-yr) | 5.08 |
| h-index | 119 |
| i10-index | 766 |
| Article processing charge | $6,300 |
| Top institutions publishing here | Johns Hopkins University |
| Journal website | www.journals.elsevier.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in The Lancet HIV per year
Citation impact of The Lancet HIV by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in The Lancet HIV
BACKGROUND: Timely assessment of the burden of HIV/AIDS is essential for policy setting and programme evaluation. In this report from the Global Burden of Disease Study 2015 (GBD 2015), we provide national estimates of levels and trends of HIV/AIDS incidence, prevalence, coverage of antiretroviral therapy (ART), and mortality for 195 countries and territories from 1980…
BACKGROUND: Understanding the patterns of HIV/AIDS epidemics is crucial to tracking and monitoring the progress of prevention and control efforts in countries. We provide a comprehensive assessment of the levels and trends of HIV/AIDS incidence, prevalence, mortality, and coverage of antiretroviral therapy (ART) for 1980-2017 and forecast these estimates to 2030 for 195 countries and…